5-trans Latanoprost (free acid) (CAS 903549-49-5)
QUICK LINKS
5-trans Latanoprost (free acid) is an F-series prostaglandin (PG) analog that was approved for ocular hypotensive drug use. It is an isopropyl ester, a prodrug form which is converted to latanoprost (free acid) by endogenous esterase enzymes. The free acid form is 200 times more potent than latanoprost as a ligand for the human recombinant FP receptor. It is an isomer of latanoprost (free acid) wherein the double bond between carbons 5 and 6 has been changed from cis (Z) to trans (E). The trans isomer of latanoprost occurs as an impurity in commercial preparations of the bulk drug product. The present compound was prepared primarily as an analytical standard for detection and quantitation of this impurity. From what can be inferred from the study of other trans isomers of F-type prostaglandins, the biological activity of this isomer is likely to be similar to that of the cis isomer. However, there are no specific published reports supporting this. 5-trans Latanoprost (free acid) is an activator of PGF2αR.
5-trans Latanoprost (free acid) (CAS 903549-49-5) References
- The pharmacology of bimatoprost (Lumigan). | Woodward, DF., et al. 2001. Surv Ophthalmol. 45 Suppl 4: S337-45. PMID: 11434936
- New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. | Nakajima, T., et al. 2003. Biol Pharm Bull. 26: 1691-5. PMID: 14646172
- Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice. | Crowston, JG., et al. 2005. Invest Ophthalmol Vis Sci. 46: 4571-7. PMID: 16303950
- Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries. | Vysniauskiene, I., et al. 2006. Invest Ophthalmol Vis Sci. 47: 295-8. PMID: 16384976
- The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II. | Sugimoto, A., et al. 2008. Biol Pharm Bull. 31: 796-801. PMID: 18451496
- Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN. | Faulkner, R., et al. 2010. J Ocul Pharmacol Ther. 26: 147-56. PMID: 20307216
- Development and validation of a liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantification of latanoprost free acid in rabbit aqueous humor and ciliary body. | Zammataro, A., et al. 2011. J Mass Spectrom. 46: 1168-74. PMID: 22124989
- A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. | Daull, P., et al. 2012. J Ocul Pharmacol Ther. 28: 515-23. PMID: 22671995
- Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models. | Mohammadi, S., et al. 2014. PLoS One. 9: e106653. PMID: 25207851
- Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes. | Sekine, Y., et al. 2018. J Ocul Pharmacol Ther. 34: 280-286. PMID: 29323612
- Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells. | Heo, JY., et al. 2020. Exp Eye Res. 194: 108019. PMID: 32222455
- A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits. | Zhou, T., et al. 2020. J Ocul Pharmacol Ther. 36: 522-528. PMID: 32310714
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
5-trans Latanoprost (free acid), 1 mg | sc-205141 | 1 mg | $69.00 | |||
5-trans Latanoprost (free acid), 5 mg | sc-205141A | 5 mg | $315.00 |